Executive Summary
In the third quarter of 2024, The Cooper Companies Inc achieved a historic milestone by surpassing the billion-dollar revenue mark, reporting consolidated revenues of $1.003 billion, an increase of 8% year-over-year. This impressive performance was driven primarily by record revenues in both the CooperVision and CooperSurgical segments, which rose by 10% and 5% respectively. The increase in profitability was also marked by a healthy operating margin improvement to 25.5% from 23.9% in the previous year, signifying effective cost management and operational efficiencies. Management remains optimistic about sustaining this growth trajectory into the next fiscal year, bolstered by innovative product offerings and strategic investments.
Key Performance Indicators
Revenue
1.00B
QoQ: 6.39% | YoY:7.80%
Gross Profit
612.60M
61.09% margin
QoQ: 5.46% | YoY:0.43%
Operating Income
192.50M
QoQ: 19.05% | YoY:26.98%
Net Income
104.70M
QoQ: 17.77% | YoY:22.74%
EPS
0.53
QoQ: 17.78% | YoY:23.26%
Revenue Trend
Margin Analysis
Key Insights
- **Revenue:** $1.003 billion, up 8% YoY
- **Gross Profit:** $612.6 million, gross margin up to 66.6% from 66.1% YoY
- **Operating Income:** $192.5 million, operating margin at 25.5%
- **Net Income:** $104.7 million, Net income up 22.74% YoY
- **EPS:** $0.96 (non-GAAP), up 14% YoY